Press Releases July 16, 2026 04:15 PM

Ridgepost Capital's Luke Sarsfield to Deliver Keynote at IPEM Global 2026

Ridgepost Capital’s CEO to keynote at major private markets conference and sponsor IPEM Global 2026 in Paris

By Ajmal Hussain
Share
Twitter Reddit Facebook LinkedIn
RPC

Ridgepost Capital announced that its Chairman and CEO, Luke Sarsfield, will deliver a keynote speech at the IPEM Global 2026 Conference, a key gathering for private capital professionals. Ridgepost will also sponsor the event, which hosts thousands of industry participants. The firm manages over $45 billion in assets across private equity, private credit, and venture capital, focusing on the middle and lower-middle market sectors worldwide.

Ridgepost Capital's Luke Sarsfield to Deliver Keynote at IPEM Global 2026
RPC
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Luke Sarsfield, Ridgepost’s CEO, is a keynote speaker at IPEM Global 2026, highlighting the company’s industry influence.
  • Ridgepost Capital will sponsor the premier private capital event, enhancing its brand visibility among global investors and private markets professionals.
  • The firm manages a significant $45 billion in diverse private market assets, emphasizing middle and lower-middle market investments across private equity, credit, and venture capital.
  • Sectors impacted include financial services, private equity, venture capital, and alternative investments markets.

DALLAS, July 16, 2026 (GLOBE NEWSWIRE) -- Ridgepost Capital, Inc. (“Ridgepost” or “Ridgepost Capital”) (NYSE: RPC), a leading private markets solutions provider, announced today that Luke Sarsfield, Ridgepost Capital Chairman and Chief Executive Officer, will be a keynote speaker at IPEM Global’s 2026 Conference. Ridgepost Capital will also serve as a sponsor at IPEM, which will be held September 8-10, 2026, in Paris.

Known as "The World's Private Capital Hub," IPEM Global brings together private capital professionals from around the world to build relationships, exchange perspectives and support continued growth across the global alternative investment industry. Over 1,600 limited partners are expected to attend alongside 2,400 firms, making IPEM one of the industry's premier networking events across private markets.

About Ridgepost Capital
Ridgepost Capital (NYSE: RPC) is a leading private markets solutions provider with over $45 billion in assets under management as of March 31, 2026. Ridgepost Capital invests across Private Equity, Private Credit, and Venture Capital in access-constrained strategies, with a focus on the middle and lower-middle market. Ridgepost Capital’s products have a global investor base and aim to deliver compelling risk-adjusted returns. For additional information, please visit www.ridgepostcapital.com.

Ridgepost Capital Investor Contact:
[email protected]

Ridgepost Capital Media Contact:
Josh Clarkson
Taylor Donahue
[email protected]


Risks

  • The announcement is largely promotional with no direct financial or operational updates, which may limit immediate market impact.
  • Private markets and alternative investment sectors can be affected by macroeconomic, regulatory, and geopolitical uncertainties that could impact Ridgepost’s asset valuations and fundraising.
  • Competition within the private markets solutions space remains intense, and ongoing market conditions may affect the firm's growth trajectory and performance.

More from Press Releases

Acoramidis Demonstrates Reversal of Cardiac Structural Disease Progression and Functional Decline and Significantly Increases Days Alive and Free from Hospitalization in ATTR-CM Aug 30, 2026 Cytokinetics Announces Additional Results from ACACIA-HCM and MAPLE-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology (ESC) Congress 2026 Aug 29, 2026 Tenax Therapeutics Announces Presentation of Phase 3 LEVEL Results in Late-Breaking Scientific Sessions at ESC Congress 2026 Aug 29, 2026 20/20 BioLabs Reschedules Investor Webinar to 2:00 p.m. Eastern Time on September 2, 2026 to Discuss OneTest™ Revenue and Expanding Commercial Opportunity Aug 28, 2026 Trinity Biotech Provides Diagnostics Business, Transformation And Corporate Update Aug 28, 2026